Catalyst

Slingshot members are tracking this event:

PDUFA date set for March 19 2016 for RTU bivalirudin liquid in Percutaneous Coronary Intervention (PCI) and Percutaneous Transluminal Coronary Angioplasty (PTCA)

Source Link:
http://hsprod.investis.com/shared/v2/irwizard/sec_item_new.jsp?epic=envision&cik=&ipage=10572690&DSEQ=1&SEQ=&SQDESC=SECTION_BODY&exp=&subsid=41

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EGRX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Mar 18, 2016
Occurred Source:
http://investor.eagleus.com/press-release/eagle-pharmaceuticals-receives-complete-response-letter-fda-kangio-rtu-bivalirudin-app
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Pdufa, Rtu Bivalirudin, Percutaneous Coronary Intervention, Percutaneous Transluminal Coronary Angioplast
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.